Can anything stop this high-flying drugmaker?

The pharmaceutical stock can still deliver.

Eli Lilly's decision to reduce the price of its popular weight loss drug makes more sense than it appears at first. The ...

We came across a bullish thesis on Eli Lilly and Company on Pebble Bites’s Substack by Christina Gan. In this article, we ...

Shares of Eli Lilly and Company (LLY), the world’s largest pharmaceutical producer, have experienced a remarkable rally this month.

(Reuters) - U.S. drugmaker Eli Lilly on Monday said it has appointed insider Lucas Montarce as its new chief financial officer, effective immediately, months after former CFO Anat Ashkenazi stepped ...

INDIANAPOLIS, Oct. 30, 2024 /PRNewswire/ -- Eli Lilly and Company (LLY) today announced its financial results for the third quarter of 2024. "Lilly had another strong growth quarter in Q3, with total ...

INDIANAPOLIS, Sept. 9, 2024 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced the appointment of Lucas Montarce as executive vice president and chief financial officer (CFO) and member ...

Eli Lilly (LLY) said that a late-stage study showed its new injected medication retatrutide helped obese patients lose up to ...

Eli Lilly and Co. on Monday elevated a company insider to chief financial officer, succeeding Anat Ashkenazi, who left three months ago to join Google and Alphabet. Lucas Montarce, who has been with ...

Three months after announcing that EVP and CFO Anat Ashkenazi would be leaving for another opportunity, Eli Lilly and Company has named a replacement. The pharma giant promoted Lucas Montarce to lead ...

Lilly’s closely watched retatrutide spurred as much as 29% weight loss in a Phase 3 study, a finding that is “raising the bar ...